Michael C. Rowbotham

Active 1987–2024

71
Papers
20,806
Citations
61
h-index
71
i10-index

Citations

Citations per year for Michael C. Rowbotham1988: 1 citations1989: 6 citations1990: 8 citations1991: 5 citations1992: 10 citations1993: 3 citations1994: 5 citations1995: 9 citations1996: 30 citations1997: 26 citations1998: 32 citations1999: 53 citations2000: 80 citations2001: 76 citations2002: 93 citations2003: 121 citations2004: 184 citations2005: 167 citations2006: 190 citations2007: 220 citations2008: 177 citations2009: 140 citations2010: 160 citations2011: 133 citations2012: 115 citations2013: 146 citations2014: 111 citations2015: 122 citations2016: 134 citations2017: 192 citations2018: 141 citations2019: 467 citations2020: 512 citations2021: 496 citations2022: 392 citations2023: 286 citations2024: 467 citations2025: 200 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,919 citing papers, 27.9% of this breakdownUnited Kingdom: 733 citing papers, 10.7% of this breakdownGermany: 435 citing papers, 6.3% of this breakdownChina: 370 citing papers, 5.4% of this breakdownCanada: 352 citing papers, 5.1% of this breakdownItaly: 285 citing papers, 4.1% of this breakdownDenmark: 254 citing papers, 3.7% of this breakdownFrance: 243 citing papers, 3.5% of this breakdownAustralia: 218 citing papers, 3.2% of this breakdownSpain: 160 citing papers, 2.3% of this breakdownNetherlands: 157 citing papers, 2.3% of this breakdownIsrael: 131 citing papers, 1.9% of this breakdown
0%27.9%Other 23.6%

Fields

  • Medicine84.4%
  • Neuroscience6.1%
  • Biochemistry, Genetics and Molecular Biology3.5%
  • Pharmacology, Toxicology and Pharmaceutics1.4%
  • Psychology1.1%
  • Health Professions0.8%
  • Other2.7%

Topics

  • Pain Mechanisms and Treatments18.7%
  • Musculoskeletal pain and rehabilitation5.3%
  • Pain Management and Opioid Use4.5%
  • Botulinum Toxin and Related Neurological Disorders4.1%
  • Pain Management and Placebo Effect3%
  • Pain Management and Treatment2.9%
  • Other61.5%

Coauthors

All papers

Open in search
  1. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2015 cited by 3,882

  2. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonia Barke, Winfried Rief, Rolf‐Detlef Treede - Pain 2018 cited by 1,134

  3. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasvinder A. Singh, Ilona Steigerwald, Vibeke Strand, Leslie Tive, Jeffrey Tobias, Ajay D. Wasan, Hilary Wilson - Pain 2020 cited by 181

  4. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

    Authors: , , , , , , , , , , , - Pain 2020 cited by 205

  5. Recommendations for the Management of Herpes Zoster

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 845

  6. Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis

    Authors: , , , , , , , - Pain 2022 cited by 85

  7. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Vardeh, Gary A. Walco, Ajay D. Wasan, Ursula Wesselmann - Journal of Pain 2022 cited by 93

  8. NeuPSIG guidelines on neuropathic pain assessment

    Authors: , , , , , , , , , , , , , , , , , , - Pain 2010 cited by 1,037

  9. Advances in Neuropathic Pain

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2003 cited by 1,209

  10. Cannabis in painful HIV-associated sensory neuropathy

    Authors: , , , , , , , , - Neurology 2007 cited by 596

  11. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Rauschkolb, Andrew S.C. Rice, Cristina Sampaio, Vladimir Skljarevski, Kenneth W. Sommerville, Brett R. Stacey, Ilona Steigerwald, Jeffrey Tobias, Ann Marie Trentacosti, Ajay D. Wasan, George A. Wells, Jim Williams, James Witter, Dan Ziegler - Pain 2012 cited by 290

  12. Informed Consent

    Authors: , , , , , - New England Journal of Medicine 2017 cited by 219

  13. Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial

    Authors: , , , , , , , - Pain 2011 cited by 126

  14. Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ewan D McNicol, Michael L. Oshinsky, Friedhelm Sandbrink, Joachim Scholz, Richard E. Scranton, Lee S. Simon, Deborah Steiner, Kenneth M. Verburg, Ajay D. Wasan, Kerry Wentworth - Pain 2021 cited by 52

  15. Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation

    Authors: , , - Neurobiology of Disease 1998 cited by 559

  16. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

    Authors: , , , - Pain 2004 cited by 518

  17. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study

    Authors: , , , , , , , , , , - Pain 2014 cited by 109

  18. The ACTTION–APS–AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis C. Turk, Steven J. Weisman, Christopher L. Wu, Daniel B. Carr, Robert H. Dworkin, Gregory W. Terman - Journal of Pain 2017 cited by 84

  19. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

    Authors: , , , , , , , , , , - Pain 2020 cited by 71

  20. Gabapentin for the Treatment of Postherpetic NeuralgiaA Randomized Controlled Trial

    Authors: - JAMA 1998 cited by 1,437

  21. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial

    Authors: , , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 651

  22. Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain

    Authors: , , , , , - New England Journal of Medicine 2003 cited by 526

  23. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

    Authors: , , , , , , , , , , , , , , , , , , , , , - Pain 2021 cited by 57

  24. Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kushang V. Patel, Andrew S.C. Rice, Michael C. Rowbotham, Friedhelm Sandbrink, Lee S. Simon, Deborah J. Steiner, Jan Vollert - Pain 2023 cited by 28